SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-09-017130
Filing Date
2009-03-12
Accepted
2009-03-12 17:17:46
Documents
12
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a09-1661_110k.htm 10-K 1823267
2 EX-10.2 a09-1661_1ex10d2.htm EX-10.2 340270
3 EX-10.11 a09-1661_1ex10d11.htm EX-10.11 116564
4 EX-10.13 a09-1661_1ex10d13.htm EX-10.13 32573
5 EX-10.14 a09-1661_1ex10d14.htm EX-10.14 30329
6 EX-23.1 a09-1661_1ex23d1.htm EX-23.1 4826
7 EX-31.1 a09-1661_1ex31d1.htm EX-31.1 10794
8 EX-31.2 a09-1661_1ex31d2.htm EX-31.2 11260
9 EX-32 a09-1661_1ex32.htm EX-32 9181
10 GRAPHIC g16611kqi001.gif GRAPHIC 12266
11 GRAPHIC g16611koi001.gif GRAPHIC 12266
12 GRAPHIC g16611ba13i001.jpg GRAPHIC 13338
  Complete submission text file 0001104659-09-017130.txt   2433102
Mailing Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121
Business Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121 8589090736
OPTIMER PHARMACEUTICALS INC (Filer) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33291 | Film No.: 09676626
SIC: 2834 Pharmaceutical Preparations